WEKO3
アイテム
{"_buckets": {"deposit": "6f32e0bd-acd5-49ce-bf95-35a1bc7a9bc0"}, "_deposit": {"created_by": 1, "id": "61947", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "61947"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00061947", "sets": ["29"]}, "author_link": ["613002", "613005", "613003", "613001", "612998", "613000", "613006", "612995", "612996", "613004", "612999", "612997"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2006-11-28", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "From 1994 to 1999, we conducted a phase I/II clinical trial for stage I non-small cell lung cancer (NSCLC) by using carbon ion beams alone, demonstrating optimal doses of 90 GyE in 18 fractions over 6 weeks and 72 GyE in 9 fractions over 3 weeks for achieving more than 95% local control with minimal pulmonary damage. In the present study, the total dose was fixed at 72 GyE in 9 fractions over 3 weeks, and at 52.8 GyE for stage IA and 60 GyE for stage 1B in 4 fractions over 1 week. Following this schedule, we conducted a phase II clinical trial for stage I NSCLC from 1999 to 2003. Most targets were irradiated from four oblique directions. A respiratory-gated irradiation system was used for all sessions. Local control and survival were assessed by the Kaplan-Meier method. For statistical testing, the long-rank test was used.\nThe local control rate for all patients was 91.5%, and those for T1 and T2 tumors were 96.3% and 84.7%, respectively. While there was significant difference (p=0.0156) in tumor control rate between T1 and T2, there was no significant difference (P=0.1516) between squamous and non-squamous. The five-year cause-specific survival rate was 67.0% (IA: 84.4, IB: 43.7), and overall survival was 45.3% (IA: 53.9, 1B: 34.2). No adverse effects greater than grade 3 occurred in the lung. Carbon beam radiotherapy, an excellent new modality in terms of high QOL and ADL, was proven to be a valid alternative to surgery for stage I cancer, especially for elderly and inoperable patients.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "NIRS-CNAO Joint Symposium on Carbon Ion Radiotherapy", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Miyamoto, Tadaaki"}], "nameIdentifiers": [{"nameIdentifier": "612995", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Baba, Masayuki"}], "nameIdentifiers": [{"nameIdentifier": "612996", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yashiro, Tomoyasu"}], "nameIdentifiers": [{"nameIdentifier": "612997", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sugane, Toshio"}], "nameIdentifiers": [{"nameIdentifier": "612998", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakajima, Mio"}], "nameIdentifiers": [{"nameIdentifier": "612999", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsujii, Hirohiko"}], "nameIdentifiers": [{"nameIdentifier": "613000", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "宮本 忠昭", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "613001", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "馬場 雅行", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "613002", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "矢代 智康", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "613003", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "須金 紀雄", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "613004", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "中嶋 美緒", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "613005", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻井 博彦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "613006", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Carbon Ion Radiotherapy in Hypofraction Regimen for Stage I Non-Small Cell Lung Cancer", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Carbon Ion Radiotherapy in Hypofraction Regimen for Stage I Non-Small Cell Lung Cancer"}]}, "item_type_id": "10005", "owner": "1", "path": ["29"], "permalink_uri": "https://repo.qst.go.jp/records/61947", "pubdate": {"attribute_name": "公開日", "attribute_value": "2006-12-07"}, "publish_date": "2006-12-07", "publish_status": "0", "recid": "61947", "relation": {}, "relation_version_is_last": true, "title": ["Carbon Ion Radiotherapy in Hypofraction Regimen for Stage I Non-Small Cell Lung Cancer"], "weko_shared_id": -1}
Carbon Ion Radiotherapy in Hypofraction Regimen for Stage I Non-Small Cell Lung Cancer
https://repo.qst.go.jp/records/61947
https://repo.qst.go.jp/records/6194719de117a-3fc1-49c9-80e1-b0111ac2beec
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2006-12-07 | |||||
タイトル | ||||||
タイトル | Carbon Ion Radiotherapy in Hypofraction Regimen for Stage I Non-Small Cell Lung Cancer | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Miyamoto, Tadaaki
× Miyamoto, Tadaaki× Baba, Masayuki× Yashiro, Tomoyasu× Sugane, Toshio× Nakajima, Mio× Tsujii, Hirohiko× 宮本 忠昭× 馬場 雅行× 矢代 智康× 須金 紀雄× 中嶋 美緒× 辻井 博彦 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | From 1994 to 1999, we conducted a phase I/II clinical trial for stage I non-small cell lung cancer (NSCLC) by using carbon ion beams alone, demonstrating optimal doses of 90 GyE in 18 fractions over 6 weeks and 72 GyE in 9 fractions over 3 weeks for achieving more than 95% local control with minimal pulmonary damage. In the present study, the total dose was fixed at 72 GyE in 9 fractions over 3 weeks, and at 52.8 GyE for stage IA and 60 GyE for stage 1B in 4 fractions over 1 week. Following this schedule, we conducted a phase II clinical trial for stage I NSCLC from 1999 to 2003. Most targets were irradiated from four oblique directions. A respiratory-gated irradiation system was used for all sessions. Local control and survival were assessed by the Kaplan-Meier method. For statistical testing, the long-rank test was used. The local control rate for all patients was 91.5%, and those for T1 and T2 tumors were 96.3% and 84.7%, respectively. While there was significant difference (p=0.0156) in tumor control rate between T1 and T2, there was no significant difference (P=0.1516) between squamous and non-squamous. The five-year cause-specific survival rate was 67.0% (IA: 84.4, IB: 43.7), and overall survival was 45.3% (IA: 53.9, 1B: 34.2). No adverse effects greater than grade 3 occurred in the lung. Carbon beam radiotherapy, an excellent new modality in terms of high QOL and ADL, was proven to be a valid alternative to surgery for stage I cancer, especially for elderly and inoperable patients. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | NIRS-CNAO Joint Symposium on Carbon Ion Radiotherapy | |||||
発表年月日 | ||||||
日付 | 2006-11-28 | |||||
日付タイプ | Issued |